Fujifilm Holdings (TSE:4901), which lost out in March to Canon (NYSE:CAJ) in the race for Toshiba‘s (TYO:6502) medical device business, is still hot to trot on the mergers & acquisitions trail. New COO Kenji Sukeno said the Japanese company is looking at pharmaceuticals and the regenerative medicine space. “There are various deals on the table, though I can’t give details,” Kenji […]
Canon
Toshiba got the cash for its medical biz before the deal closed
Toshiba (TYO:6502) managed to book the $5.95 billion sale of its medical business to Canon (NYSE:CAJ) before the deal actually closed, by setting up a holding company with just $300 in assets to skirt Japanese anti-trust regulations. In March, Toshiba granted Canon exclusive negotiating rights to buy Toshiba Medical Systems after a hotly contested auction. Toshiba badly needed the ¥665.5 […]
Materialise NV, Canon ink Japanese distro deal
Materialise (NSDQ:MTLS) said today it inked a distribution deal with Canon (NYSE:CAJ) Lifecare Solutions to distribute its Materialise Mimics Innovation software and care suits in Japan. Through the agreement, workstations and 3D printers offered by Canon Lifecare Solutions will be offered with Materialise’s open software solutions, including the newly launched Materialise Mimics inPrint designed to allow hospitals to […]
Toshiba deals medical biz to Canon for $5.9B as U.S. authorities launch accounting probe
Toshiba (TYO:6502) said yesterday that it inked a deal to sell its medical device business to Canon (NYSE:CAJ) for $5.9 billion, as the U.S. Justice Dept. and the SEC probed the accounting practices in its U.S. businesses, and today said it plans to lay off an additional 3,000 workers. Toshiba last week granted Canon exclusive negotiating rights to buy […]
Jilted Fujifilm questions Toshiba on timing of medical biz sale to Canon
Fujifilm Holdings (TSE:4901), which lost out last week to Canon (NYSE:CAJ) in the race to be picked as preferred bidder for conglomerate Toshiba‘s (TYO:6502) medical device business, questioned Toshiba today on the timing of the deal for Toshiba Medical Systems. In a letter to embattled Toshiba, Fujifilm cited media reports saying profits from the sale would contribute to Toshiba’s finances […]
Canon wins exclusive negotiating rights for Toshiba Medical
Canon (NYSE:CAJ) beat out Fujifilm Holdings (TSE:4901) for the exclusive right to negotiate with Toshiba (TYO:6502) for its medical device business, the embattled Japanese conglomerate said today. “Toshiba has carried out a close evaluation of the overall proposals received from companies that expressed an interest in acquiring [Toshiba Medical Systems Corp.], including their appraisal of TMSC’s value and the feasibility […]
Fujifilm, Canon lead the running in $6B race for Toshiba Medical
Fujifilm Holdings (TSE:4901) and Canon (NYSE:CAJ) are at the head of the crowd looking to pick up Toshiba‘s (TYO:6502) medical device business, according to The Wall Street Journal, at a price possibly reaching $6 billion. The 2nd round of bidding for the division is slated to close Friday, with Toshiba likely selecting a single bidder to enter exclusive […]
Bidding war heats up for Toshiba Medical
A bidding war for Toshiba (TYO:6502) subsidiary Toshiba Medical is reportedly heating up among a slew of private equity players and rival corporations. Toshiba, which said last month that it’s seeking outside investors to buy a stake in the healthcare business amid laying off nearly 7,000 workers, wants to focus on its core nuclear energy and chip businesses. Private equity shops KKR and Bain […]
T2 Biosystems, Canon to develop Lyme disease test
T2 Biosystems (NSDQ:TTOO) and Canon U.S. Life Sciences are teaming up to develop a diagnostic test panel for the rapid detection of Lyme disease.
CAZ Investments raises $29M fund | Wall Street Beat
CAZ Investments raised a nearly $29 million funding round it plans to use to back medical companies that already have products on the market.
The Houston-based asset management firm reeled in $28.7 million from 61 unnamed investors, according to a regulatory filing.
CAZ Investments chairman Christopher Zook said the firm plans to use the cash to invest in commercialized companies.
Diabetes: Medtronic wins clearance for next-gen clinical continuous glucose monitor | Regulatory Roundup
Medtronic Inc. (NYSE:MDT) won FDA clearance for its next generation iPro2 Professional continuous glucose monitor.
The iPro2 Professional is a clinician-owned device that collects glucose data from a sensor inserted into a patient’s skin.
The device tracks the patient’s glucose levels for 3 days, collecting data as many as 288 times each day. The information may provide insight into how diet, medication and daily activities affect a patient’s glucose levels.